Corbus Pharmaceuticals Holdings, Inc.CRBPNASDAQ
Loading
| Metric | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 |
|---|---|---|---|---|---|
| Revenue Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Gross Profit Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| EBITDA Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Operating Income Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Net Income Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| EPS Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| EPS Diluted Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Weighted Average Shares Growth | +175.32% | +333.84% | +335.19% | +2.44% | +9.34% |
| Weighted Average Shares Diluted Growth | +175.32% | +333.84% | +335.19% | +2.44% | +9.34% |
| Dividends per Share Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Operating Cash Flow Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Free Cash Flow Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Receivables Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Inventory Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Asset Growth | +451.35% | +11.28% | -17.70% | -33.29% | +7.90% |
| Book Value per Share Growth | +0.00% | -69.79% | -79.68% | -40.23% | -5.28% |
| Debt Growth | -84.49% | -83.49% | -83.40% | -43.24% | -49.58% |
| R&D Expense Growth | +25.89% | +171.47% | +121.22% | +93.01% | +109.47% |
| SG&A Expenses Growth | +23.42% | +7.04% | +1.07% | -24.27% | -4.38% |